Capital World Investors’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.8M | Hold |
13,361,096
| – | – | 0.01% | 418 |
|
|
2025
Q1 | $29.8M | Buy |
13,361,096
+5,427,483
| +68% | +$12.1M | ﹤0.01% | 443 |
|
|
2024
Q4 | $23.2M | Buy |
+7,933,613
| New | +$23.2M | ﹤0.01% | 452 |
|
|
2024
Q3 | – | Sell |
-5,318,793
| Closed | -$15.7M | – | 535 |
|
|
2024
Q2 | $15.7M | Sell |
5,318,793
-3,032,500
| -36% | -$8.98M | ﹤0.01% | 455 |
|
|
2024
Q1 | $37.8M | Hold |
8,351,293
| – | – | 0.01% | 415 |
|
|
2023
Q4 | $47.7M | Sell |
8,351,293
-69,200
| -0.8% | -$395K | 0.01% | 389 |
|
|
2023
Q3 | $38.7M | Hold |
8,420,493
| – | – | 0.01% | 399 |
|
|
2023
Q2 | $54.4M | Sell |
8,420,493
-907,000
| -10% | -$5.86M | 0.01% | 367 |
|
|
2023
Q1 | $70.3M | Hold |
9,327,493
| – | – | 0.01% | 356 |
|
|
2022
Q4 | $94.5M | Sell |
9,327,493
-253,266
| -3% | -$2.57M | 0.02% | 340 |
|
|
2022
Q3 | $94.8M | Sell |
9,580,759
-3,457,598
| -27% | -$34.2M | 0.02% | 339 |
|
|
2022
Q2 | $139M | Sell |
13,038,357
-5,229,418
| -29% | -$55.7M | 0.03% | 306 |
|
|
2022
Q1 | $178M | Sell |
18,267,775
-3,783,928
| -17% | -$36.9M | 0.03% | 310 |
|
|
2021
Q4 | $315M | Buy |
22,051,703
+2,230,296
| +11% | +$31.9M | 0.05% | 267 |
|
|
2021
Q3 | $397M | Buy |
19,821,407
+6,405,970
| +48% | +$128M | 0.07% | 235 |
|
|
2021
Q2 | $295M | Buy |
13,415,437
+9,254,567
| +222% | +$204M | 0.05% | 267 |
|
|
2021
Q1 | $141M | Buy |
4,160,870
+521,447
| +14% | +$17.7M | 0.03% | 332 |
|
|
2020
Q4 | $146M | Buy |
+3,639,423
| New | +$146M | 0.03% | 310 |
|